13F data as of 2025-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

45332Y109

FAQ

Who are the top institutional investors holding INARI MEDICAL INC (NARIUSD)?

Major stakeholders currently include SoundView Advisors Inc. ($250.0K), IFP Advisors, Inc ($141.1K), Total Clarity Wealth Management, Inc. ($4.1K). Based on the latest 13F filings, there are a total of 4 tracked investment funds and institutions maintaining positions in NARIUSD.

What is the overall institutional sentiment toward NARIUSD recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $2.8B, driven by 2 managers accumulating shares while 60 reduced their exposure.

Which institutions have been selling or reducing their NARIUSD positions?

In the latest period, 0 funds trimmed their holdings, and 60 managers completely exited their positions. The aggregate reported sell value was $873.7M.

Are there any notable investors adding NARIUSD to their portfolios?

Yes, buying activity remains notable. 2 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $145.2K.